Lackner Mark — SEC Form 4 filings

SEC reporting owner CIK 1777413. 3 Form 4 filings on record with FilingPulse; latest filed 2025-02-05.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-02-05 to 2025-02-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Zentalis Pharmaceuticals, Inc. (ZNTL)Chief Scientific Officer33 legs · 20,364 sh · $56,6444

Form 4 filings — Lackner Mark

FiledFormIssuerReported transactionsSource
2025-02-054Zentalis Pharmaceuticals, Inc. (ZNTL)Grant/award (A): 335,907 @ $0 · Sale (S): 14,368 @ $1.71 · Grant/award (A): 124,714 (derivative) @ $0EDGAR
2025-01-034Zentalis Pharmaceuticals, Inc. (ZNTL)Sale (S): 4,411 @ $3.12EDGAR
2024-02-054Zentalis Pharmaceuticals, Inc. (ZNTL)Grant/award (A): 141,000 @ $0 · Sale (S): 1,585 @ $11.54 · Grant/award (A): 141,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1777413 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →